Vicki L. Sato, PhD, has served on the NeuroPhage Board of Directors since 2008. Dr. Sato is Professor of Management Practice at Harvard Business School and also Professor of the Practice in the Department of Molecular and Cell Biology, Harvard University. She is a business advisor to Atlas Ventures and other enterprises in the biotechnology and pharmaceutical industries. Dr. Sato retired recently from Vertex Pharmaceuticals, where she served as President since 2000, with responsibility for research and development, business and corporate development, commercial operations, legal, and finance. Prior to becoming President, she was Chief Scientific Officer, Senior Vice President of Research and Development, and Chair of the Scientific Advisory Board. Before joining Vertex, Dr. Sato was Vice President of Research at Biogen, Inc., participating in the executive management of the company and serving as a member of the Biogen Scientific Board. Currently, Dr. Sato is a member of the Board of Directors of Bristol Myers Squibb Company, PerkinElmer Corporation, and Alnylam Pharmaceuticals. She is also Chair of the Overseers of the Isabella Stewart Gardner Museum. Dr. Sato received her AB from Radcliffe College, and her AM and PhD degrees from Harvard University. Following postdoctoral work at both the University of California Berkeley and Stanford Medical Center, Dr. Sato was appointed to the faculty of Harvard University, where she was an Assistant and Associate Professor of Biology.